المؤلفون: Thomas John, Hiroshi Sakai, Satoshi Ikeda, Ying Cheng, Kazuo Kasahara, Yuki Sato, Yoshiro Nakahara, Masayuki Takeda, Hiroyasu Kaneda, Helong Zhang, Makoto Maemondo, Koichi Minato, Takeshi Hisada, Yuki Misumi, Miyako Satouchi, Katsuyuki Hotta, Ang Li, Abderrahim Oukessou, Shun Lu

المصدر: International journal of clinical oncology. 27(4)

مصطلحات موضوعية: Lung Neoplasms, Nivolumab, Oncology, Adolescent, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Humans, Surgery, Hematology, General Medicine, Neoplasm Recurrence, Local, Ipilimumab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6cbc8f9f68fcad9ee86f4177c64647
https://pubmed.ncbi.nlm.nih.gov/35182247

المؤلفون: Nobukazu Fujimoto, Laurent Greillier, Thierry Jahan, Aaron S. Mansfield, Praveen Aanur, Yolanda Bautista, Solange Peters, Christine Baudelet, Abderrahim Oukessou, Anna K. Nowak, Dariusz M. Kowalski, Arnaud Scherpereel, Anne S. Tsao, Scott J. Antonia, Jerónimo Rodríguez-Cid, Paul Baas, Youssef Oulkhouir, Gérard Zalcman, Sanjay Popat, Robin Cornelissen, Francesco Grossi

المساهمون: Leiden University Medical Center (LUMC), Universiteit Leiden, CHU Lille, Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), The University of Western Australia (UWA), Lausanne University Hospital, MD Anderson Cancer Center [Houston], The University of Texas Health Science Center at Houston (UTHealth), Mayo Clinic [Rochester], The institute of cancer research [London], Helen Diller Family Comprehensive Cancer Center [San Francisco], H. Lee Moffitt Cancer Center and Research Institute, Hôpital Côte de Nacre [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Hospital de Pediatria [Mexico City, Mexico] (Centro Médico Nacional Siglo XXI), Erasmus University Medical Center [Rotterdam] (Erasmus MC), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Nord [CHU - APHM], Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Maria Sklodowska-Curie National Research Institute of Oncology [Krakow, Poland], Instituto Nacional de Enfermedades Respiratorias [México, Mexico], Bristol-Myers Squibb [Princeton], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Cité (UPCité), Service d'oncologie multidisciplinaire innovations thérapeutiques [Hôpital Nord - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], karlsen, melanie, Pulmonary Medicine

المصدر: The Lancet Digital Health
The Lancet Digital Health, 2021, 397 (10272), pp.375-386. ⟨10.1016/S0140-6736(20)32714-8⟩
The Lancet, 397(10272), 375-386. ELSEVIER SCIENCE INC
The Lancet
The Lancet, 2021, 397 (10272), pp.375-386. ⟨10.1016/S0140-6736(20)32714-8⟩
The Lancet, 397(10272), 375-386. Elsevier Ltd.

مصطلحات موضوعية: Male, medicine.medical_specialty, [SDV.IMM] Life Sciences [q-bio]/Immunology, Phases of clinical research, Ipilimumab, [SDV.CAN]Life Sciences [q-bio]/Cancer, 030204 cardiovascular system & hematology, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, 03 medical and health sciences, chemistry.chemical_compound, Antineoplastic Agents, Immunological, 0302 clinical medicine, SDG 3 - Good Health and Well-being, [SDV.CAN] Life Sciences [q-bio]/Cancer, Drug Therapy, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, 030212 general & internal medicine, Lung cancer, Aged, business.industry, Mesothelioma, Malignant, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, General Medicine, Interim analysis, medicine.disease, Carboplatin, Regimen, Nivolumab, Pemetrexed, chemistry, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645b83946b062223362a708abde6703c
https://inria.hal.science/hal-03526460

المؤلفون: Pierre-Jean Souquet, David P. Carbone, Michael Schenker, Shun Lu, S. Meadows-Shropshire, A. Alexandru, Pamela Salman, Hiroshi Sakai, Jaafar Bennouna, Maurice Pérol, Enriqueta Felip, Alejo Lingua, J. Yan, Juliana Janoski de Menezes, B. Zurawski, Martin Reck, Arnaud Scherpereel, C. Martin, Eduardo Richardet, Abderrahim Oukessou, Tudor-Eliade Ciuleanu, Manuel Cobo, O. Juan-Vidal, Pedro Rafael Martins De Marchi, Thomas John, Luis Paz-Ares, Shruti Agrawal

المساهمون: Universidad Complutense de Madrid = Complutense University of Madrid [Madrid] (UCM), The Oncology Institute 'Prof. Dr. Ion Chiricuţă' [Cluj-Napoca, Romania] (TOI), Instituto de Investigación Biomédica [Malaga, Spain] (IBIMA), SF Nectarie Oncology Center [Craiova, Romania], Ambulatorium Chemioterapii [Bydgoszcz, Poland] (AC), Hospital Nossa Senhora Da Conceição [Porto Alegre, Brazil] (HNSDC), Instituto Oncológico De Córdoba [Córdoba, Argentina] (IODC), Immunogenic Cell Death and Mesothelioma Therapy (CRCINA-ÉQUIPE 4), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Centre hospitalier universitaire de Nantes (CHU Nantes), Vall d'Hebron Institute of Oncology [Barcelone] (VHIO), Vall d'Hebron University Hospital [Barcelona], Hospital Universitario La Fe [Valencia, Spain] (HU), Oncology Institute of Bucharest Professor Doctor Alexandru Trestioreanu [Bucharest, Romania] (OIB), Saitama Cancer Center [Saitama, Japan] (S2C), Instituto Medico Rio Cuarto SA [Córdoba, Argentina] (IMRC), Fundacion Arturo Lopez Perez [Santiago, Metropolitana, Chile] (FALP), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Barretos Cancer Hospital [São Paulo, Brazil], Instituto Alexander Fleming [Buenos Aires, Argentina] (IAF), Centre Léon Bérard [Lyon], Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), University of Lille, CHU Lille, Shanghai Jiao Tong University [Shanghai], Austin Hospital [Melbourne], Austin Health, Ohio State University [Columbus] (OSU), Bristol-Myers Squibb [Princeton], German Center for Lung Research, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Hospital Universitari i Politècnic La Fe = University and Polytechnic Hospital La Fe, Bernardo, Elizabeth

المصدر: LANCET ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Lancet
Lancet, Elsevier, 2021, 22 (2), pp.198-211. ⟨10.1016/S1470-2045(20)30641-0⟩
The Lancet
The Lancet, 2021, 22 (2), pp.198-211. ⟨10.1016/S1470-2045(20)30641-0⟩

مصطلحات موضوعية: Male, medicine.medical_specialty, Ipilimumab, [SDV.CAN]Life Sciences [q-bio]/Cancer, Neutropenia, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Aged, Neoplasm Staging, business.industry, Hazard ratio, Middle Aged, medicine.disease, Interim analysis, 3. Good health, respiratory tract diseases, Regimen, Nivolumab, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, Febrile neutropenia, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa94d86fd54759cc80a6aa8c6a4c99f6
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13780

المؤلفون: Ben C. Creelan, Ang Li, Mohamed K. Mohamed, Nivedita Aanur, Shruti Agrawal, Jason C. Chandler, Kenneth B. Blankstein, Michael McCleod, Craig H. Reynolds, Abderrahim Oukessou, Leora Horn, Petros Nikolinakos, David R. Spigel, Tarek Mekhail, David M. Waterhouse

المصدر: Cancer Chemotherapy and Pharmacology. 81:679-686

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Toxicology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Pharmacokinetics, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Tissue Distribution, Pharmacology (medical), 030212 general & internal medicine, Dosing, Infusions, Intravenous, Adverse effect, Aged, Retrospective Studies, Aged, 80 and over, Pharmacology, Brain Neoplasms, Infusion time, business.industry, Incidence (epidemiology), Middle Aged, Prognosis, Discontinuation, Safety profile, Nivolumab, Oncology, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Neoplasm Recurrence, Local, Safety, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebe506835efb282ffcf7603c305cda06
https://doi.org/10.1007/s00280-018-3527-6

المؤلفون: Gérard Zalcman, Paul Baas, Abderrahim Oukessou, Anna K. Nowak, Arnaud Scherpereel

المصدر: The Lancet. 398:302

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Pleural mesothelioma, business.industry, Internal medicine, medicine, General Medicine, Mesothelioma, medicine.disease, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ea3cdb5571b9234147429e2fc7bea3b1
https://doi.org/10.1016/s0140-6736(21)00876-x

المؤلفون: J McKendrick, Catherine Davis, David Cella, Teresa Zyczynski, Ravi Vij, Antonio Palumbo, Abderrahim Oukessou, Amber Kudlac

المصدر: Annals of Hematology

مصطلحات موضوعية: Male, medicine.medical_specialty, Health-related quality of life, Immunology, Pain, Antibodies, Monoclonal, Humanized, Dexamethasone, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Multiple myeloma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Elotuzumab, Bone pain, Lenalidomide, Aged, Response rate (survey), Patient-reported outcomes, business.industry, Hematology, General Medicine, Middle Aged, medicine.disease, humanities, Thalidomide, Survival Rate, 030220 oncology & carcinogenesis, Quality of Life, Female, Original Article, medicine.symptom, business, Progressive disease, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4777a1be5ff8b83930418b88d73890
https://hdl.handle.net/10453/130893

المؤلفون: B. Bregman, Agnès Guerci-Bresler, Mauricette Michallet, Martine Gardembas, Anne Vekhoff, Michel Tulliez, Françoise Huguet, Kamel Ghomari, Nathalie Cambier, Selim Corm, Abderrahim Oukessou

المصدر: Current Medical Research and Opinion. 26:307-317

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Treatment response, Adolescent, Drug resistance, Chronic myeloid leukaemia, Unmet needs, Young Adult, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Disease management (health), Psychiatry, neoplasms, Aged, Retrospective Studies, Aged, 80 and over, Health Services Needs and Demand, business.industry, Professional Practice, Imatinib, General Medicine, Middle Aged, Clinical Practice, Female, Observational study, France, business, Algorithms, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cc99a64b5346afc0b85f7f12180913
https://doi.org/10.1185/03007990903479299

المؤلفون: Hartmut Goldschmidt, Catherine Davis, Sergey Popov, Gordon Cook, David Cella, Antonio Palumbo, David J. Kuter, Ravi Vij, Brian G.M. Durie, Abderrahim Oukessou, Philippe Moreau, Teresa Zyczynski

المصدر: Blood. 126:2093-2093

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Patient survival, Cell Biology, Hematology, Biochemistry, Disease severity, Preliminary report, Median time, Family medicine, Medicine, Observational study, Prospective research, business, Cardiac disorders, Cohort study

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a438752d04e4950c99249ecf316284b5
https://doi.org/10.1182/blood.v126.23.2093.2093

المؤلفون: Jean-Luc Laï, B. Bregman, Claude Preudhomme, Ariane Leroyer, Stéphanie Poulain, Abderrahim Oukessou, Thierry Facon, Jean-Baptiste Micol, Agnès Daudignon, Selim Corm

المصدر: Journal of Clinical Oncology. 26:7088-7088

مصطلحات موضوعية: Cancer Research, Pediatrics, medicine.medical_specialty, business.industry, Prevalence, Imatinib, Retrospective cohort study, Newly diagnosed, Chronic myeloid leukaemia, stomatognathic diseases, Survival data, Oncology, Nord pas de calais, otorhinolaryngologic diseases, medicine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b73ddf52d517f9ae5a0e1a0ee3cc2d47
https://doi.org/10.1200/jco.2008.26.15_suppl.7088

المؤلفون: Mauricette Michallet, Michel Tulliez, Sélim Corm, Martine Gardembas, Françoise Huguet, Abderrahim Oukessou, Bruno Bregman, Anne Vekhoff, Kamel Ghomari, Nathalie Cambier, Agnès Guerci-Bresler

المصدر: Current Medical Research & Opinion; Jan2010, Vol. 26 Issue 2, p307-317, 11p

مصطلحات موضوعية: TREATMENT of chronic myeloid leukemia, IMATINIB, HEALTH outcome assessment, DRUG resistance, CYTOGENETICS, POLYMERASE chain reaction, ALTERNATIVE medicine

مصطلحات جغرافية: FRANCE